CALCULATION OF
Form
(Form Type)
(Exact Name of Registrant as Specified in its Charter)
Table 1—Newly Registered Securities |
||||||||||||||||||||||||||
|
|
Security |
|
Security Class Title |
|
Fee Calculation Rule |
|
Amount Registered(1) |
|
|
Proposed Maximum Offering Price Per Unit |
|
|
Maximum Aggregate Offering Price |
|
|
Fee Rate |
|
|
Amount of Registration Fee |
|
|||||
|
|
|
|
|
|
(2) |
|
$ |
(3) |
|
$ |
|
|
|
|
|
$ |
|
||||||||
Total Offering Amounts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
$ |
|
||
Total Fee Offsets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
Net Fee Due |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
(1) |
In accordance with Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall be deemed to cover any additional shares of common stock that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.
|
(2) |
Consists of (i) 226,931 shares issuable under the Xilio Therapeutics, Inc. 2021 Stock Incentive Plan, (ii) 41,718 shares issuable under the Xilio Therapeutics, Inc. 2021 Employee Stock Purchase Plan, and (iii) 32,485 shares issuable under the Xilio Therapeutics, Inc. Second Amended and Restated 2022 Inducement Stock Incentive Plan.
|
(3) |
Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act and based upon the average of the high and low prices of the registrant's common stock as reported on the Nasdaq Capital Market on March 19, 2026. |